Pr. Francesco Giammarile is a physician licenced in Italy and in France, with a post-graduate degree in nuclear medicine, a PhD in biophysics and MSc in oncology, pedagogy, hyperbaric medicine and nuclear physics.
At present, he works as Senior Technical Officer for the International Atomic Energy Agency for the development of Nuclear Medicine in low to middle income countries.
From 2006 to 2017, he was a professor in the nuclear medicine department of the university hospital in Lyon, a senior lecturer in the medical school and an associate researcher in the university lab EA3738 (“Ciblage Thérapeutique en Oncologie”). His research activity combines both basic and applied clinical aspects. His main field of interest is nuclear oncology, including diagnosis with special emphasis in hybrid imaging such SPECT/CT and PET/CT, sentinel lymph node and surgical guided procedures, and radionuclide therapy. More specifically, he has developed a research program evaluating the clinical impact of PET imaging in therapy response and outcome prediction in lymphoma and lung cancer patients. He coordinated several national and international clinical projects and is involved in several research programs funded by the French Government, in the field of general oncology, lymphoma, lung cancer, breast cancer, colorectal cancer, osteosarcoma, neuroblastoma, neuroendocrine tumours. Since 2017, he is the Congress Chair of the European Association of Nuclear Medicine.
He has over 170 co-authored indexed publications in peer reviewed journals, in addition to about 100 publications in national journals, 120 publications in conference proceedings and several books and CD-ROM in biophysics, for medical students, and nuclear oncology, for physicians. On Google Scholar, he has about 4800 quotations, and a H-index of 36.